Outlook Magazine, Summer 1995 by unknown
Washington University School of Medicine
Digital Commons@Becker
Outlook Magazine Washington University Publications
1995
Outlook Magazine, Summer 1995
Follow this and additional works at: http://digitalcommons.wustl.edu/outlook
Part of the Medicine and Health Sciences Commons
This Article is brought to you for free and open access by the Washington University Publications at Digital Commons@Becker. It has been accepted
for inclusion in Outlook Magazine by an authorized administrator of Digital Commons@Becker. For more information, please contact
engeszer@wustl.edu.
Recommended Citation
Outlook Magazine, Summer 1995. Central Administration, Medical Public Affairs. Bernard Becker Medical Library Archives.
Washington University School of Medicine, Saint Louis, Missouri. http://digitalcommons.wustl.edu/outlook/113
Washington University School of Medicine Summer 1995 








U.S. Representative Jim Talent, left, learns about the underlying TI 
causes of autoimmune disorders such as lupus and arthritis from of 
James Lefkowith , M.D. , associate professor of medicine. Talent visited of 
the School of Medicine campus in April at the invitation of the Eastern de 
Missouri Chapter of the Arthritis Foundation. In addition to Lefkowith , of 
he met with key administrators of the medical school and the arthritis ~ er. 
foundation to discuss the importance of federal funding for basic in 





































il 	 The image reveals the affected areas 
of the brain six days afte r the rupture 
of an aneurysm. The purple area 
denotes tissue that has died from lack 
of blood flow. A new PET study is 
enabling researchers to evaluate brain 
~ injury sooner - during the critical 
first hours afte r the event , when most
., 
\I 	 of the damage occurs. As a result , they 
hope to intervene and prevent or 
minimize permanent damage before it 
happens . For more on the study, see 
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P E 0 P 
Wells To Preside Over Surgical Association 
Samuel A. Wells, Jr., M.D. 
SAMUEL A. Wells, Jr., M.D., Bixby Professor of Surgery and head of the Department 
of Surgery, has been elected presi­
dent of the American Surg ical 
Association. 
Wells was e lected to the post by 
a vote of the organiza tion's members 
during the associatio n's 115th 
annual meeting, held in April in 
Chicago. He will serve as the 
associatio n's president and chief 
executive officer for o ne year and 
also will presid e over next yea r's 
annual meeting. 
T wo other Washington Univer­
sity surgeo ns have served as presi­
dent of the assoc iation: Evarts A. 
Graham, M.D., former head of the 
Departmen t of Surgery, and Eugene 
M. Bricker, M.D., professor emeritus 
of the division o f genera l surgery. 
Wells is known for his research and 
clinical expe rtise in oncology and 
endocrino logy. He has been particu­
larly interested in cancer gene tics, 
and last year he and his collabora­
tors at the School of Medicine 
developed a genet ic test that 
accurately identifies individ uals who 
have inherited a certain type of 
thy ro id cancer. Surgery to remove 
the thyroid gland in affected family 
members prevents the development 
of thyroid cancer. 
Wells has been a member of 
the American Surgical Association 
since 1976. He also is a fellow of the 
American College of S urgeons and 
serves as vice-chairman of its Board 
of Regents. He is ed itor- in-ch ief of 
the Journal of the American College 
of S.trgeons .• 
Wynder Prize For Preventive Medicine 

FOUR fourth-year medical students received the first annual Wynder Prize for 
Preventive Medicine in April. 
Krista Johnson and Jonathan 
Primack received the award for work 
pertaining to tuberculosis that was 
done between their first and second 
years of medical school. The two 
performed skin tests on psychiatric 
inpatients and ou tpa tients and 
found a 10 percent rate of PPD 
positivity, which was much higher 
than expected. They also tested 
negative pressure isola ti on rooms in 
10 St. Louis area hosp itals and found 
that nearly half worked improperly 
or did not wo rk a t all. 
Bobbi H awk and Douglas Pogue 
received the award for the ir work in 
1992 on the Reproductive Heal th 
Education Project. The two worked 
with teachers, comm unity leaders 
and parents to develop a pilo t 
curriculum for the Ferguso n Middle 
School to address anatom y, phYSiol­
ogy, sexua lly transmitted diseases, 
contraception and relationships and 
self-esteem. The ir pilot project has 
grow n significantly so that now 
some 350 Ferguson Middle School 
students receive reproductive health 
education instruction each year. 
Ernst Wynder, M.D., a 1950 
Washington University alumnus, 
established the prize.• 
L E 

Klahr To Council 
S
AULO Kl ahr, M.D., John E. 
and Adaline S imon Professor 
and vice-chairman of the 

Department of Medicine, h as been 
appointed to the National Diabetes 
and Digestive and Kidney Diseases 
Advisory C ounc il (NIDDK). 
Donna Shalala, U.~. Secretary 
of Health and Human Services 
(HHS), appoin ted Klahr, who a lso is 
chief o f medic ine at Jewish Hospi ta l, 
to the council. The body makes 
recommendations about the study 
and treatment of kidney disease and 
diabetes to HHS, the National 
Institutes of Health and the NIDDK.• 
Robert L. Kroc 
Professorship 
PAU L Allen, Ph.D., professor of pathology, has been named the Robert L. Kroc Professo r of 
Pathology. 
Allen, who joined the Schoo l of 
Medicine faculty in 1985, studies 
how the immune system distin­
guishes between "se lf" and "non­
self," and how immune system 
disturbances can lead to autoim­
mune diseases such as diabe tes, 
rheumatoid arthriti s and multiple 
scleros is. 
The endowed professorship 
was established in 1985 to suppo rt 
biomedica l research in diabetes and 
endocrine diseases. It is funded by 
the late Ray A. Kroc, founder of 
McDonald's Corp. The endowment 
is named for hi s bro ther, Robert L. 
Kroc , M. D., in recognition of his 
acco mplishments as a uni vers ity 
teacher and pharmaceutical 
researcher. 
Allen is the second recipient o f 
the Kroc professorship. Paul E. Lacy, 
M.D., Ph.D., former head of the 
Department of Pathology and now 
professor emeritus of pathology, was 
the fi rst. • 
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TANLEY J Korsmeyer, M.D., 
professor of med icine and 
pathology, has been elected 
into the National Academy of 
Sciences, one of the highest honors 
that can be accorded a U .S. scientist. 
Korsmeyer, who is chief o f the 
divis ion of molecular oncology in the 
departments of medicine and 
patho logy and an investigator of the 
Howard Hughes Medica l Institute, is 
known for his ground breaking 
research on the genetic control of 
programmed cell death , a process in 
which cells are genetically predes­
tined to die at a strategic time. 
Programmed cell death is known to 
occur as a normal part of human 
development. In recent yems , 
Korsmeyer and other researchers 
around the world have discove red 
that programmed cell death plays an 
important role in many human 
diseases including cardiovascular 
cond itions, Parkinson's disease and 
autoimmune disorders. 
His laboratory has identifi ed 
seve ral ge nes that prevent and 
initi a te programmed cell death. In 
1985, he and his colleagues identi ­
fied a new cancer-causing gene 
called Bcl-2, referred to as a "cell 
savior" for its ab ility to block 
programmed cell death. Korsmeyer 
has found that Bd-2 may be linked 
to lymphomas. The group later 
discovered another gene, called 
HOXll, which is invo lved in 
development ofT cell leukem ia. In 
recent years, he and his colleagues 
have uncovered several other ge nes, 
Bax and Bad, that promote cell death 
and regu late the balance between 
cell prolifera tion and cell demise. 
Establi shed in 1863 , the Na­
tional Academy of Sciences is a 
private organ iza tion of scientists and 
engineers dedicated to furthering 
science and its use to benefit the 
public. • 
Shile Receives Radiology Fellowship 

Peter E. Shile, M.D. 
PETER E. Shile, M.D., ass istant professor of radi o logy at Washington University's 
Mallinckrodt Institute of Radiology, 
has recei ved the GE-AUR Radiol ­
ogy Research Academic Fellowship. 
Co-sponsored by General 
Electric Medical Systems and the 
Association of Univer­
sity Radio logists, the 
two-yea r fell owships 
support approved 
resea rch projects and 
encourage young 
investiga tors to pursue 
careers in rad iology 
resea rch. 
Shile's research 
focuses on the eva lua­
tion of digital display 
techno logies in 
mammography. He 
currently is collaborat­
ing with scientists in MIR's elec­
tronic radiology labora tory to 
improve diagnos tic accuracy in 
mammography by deve loping new 
ways to process and di splay image 
information in mammograms. 
Shile will receive a $50,000 
annual stipend fo r his project. • 
Honors To Goate For Alzheimer's Research 
of South Flor ida, 
T ampa, in 1991, she 
found a mutation in the 
amyloid precursor 
pro te in (APP) gene on 
chromosome 21. The 
gene produces beta­
amyloid pro tein, the 
pro tein found in the 
sen i1e plaques and 
neurofi bri lIary tangles 
that form in the brains 
of Alzhe ime r's victims. 
Alison M. Goate, D.Phil. 
ALISON M. Goate, D.Phil., assoc iate professor of psychia­try and genetics, is one of 
four scientists to receive a Metro­
politan Life Foundation Award for 
Alzheimer's disease research. 
Ooate is internationally kn own 
for her discovery of the first gene tic 
mutation linked to an inherited form 
of Alzheimer's disease. W orking with 
John Hardy, Ph.D., of the University 
The speci fic 
abnormality identified 
by Ooate was connected to inhe r­
ited cases of early-onset Alzheimer's 
disease which affects members of 
particular fam ilies before the 
age of 60. 
Ooate's discovery has led 
researchers to look for additio nal 
genetic abnormalities that could 
be linked to other subtypes of 
Alzheime r's di sease .• 




EVE N T S 

Mark Wrighton Assumes Chancellor's Office 

ON JULY 1, 1995, Mark S. Wrighton, Ph.D., officially became Washington 
University's 14th chancellor. 
Wrighton succeeds retiring 
Chancellor William H. Danforth 
whose tenure at tne University's 
helm spanned 24 years. 
Wrighton, 45, come. to 
Washington University from 
the position of provost and 
chief academic officer at the 
Massachusetts Institute of 
Technology (MIT). He was 
named to the post of 
chancellor on April 10 after 
a yearlong, nationw ide 
search that began after 
Danforth announced his 
intention to retire. 
"Washington University 
is most fortunate to find a 
person like Mark Wrighton 
to continue the traditio n of 
strong leadership among its 
chancellors - leadership 
that has guided our emer­
gence as one of the world's 
great teaching and research 
institutions," said William 
M. Van Cleve, chair of the 
search committee and of the 
Board of Trustees. "In ou r 
search, we sought a leader 
who could help us chart a 
course through the man y 
challenges faCing higher 
education in the next few 
years. Mark Wrighton is the person 
to accomplish that." 
After reviewing hundreds of 
nominees, the search committee 
unanimousl y recommended 
Wrighton, and the board unani ­
mously supported that recommenda­
tio n . "We looked long and hard for a 
wo rthy successor to Bill Danfo rth," 
Van Cleve said. 
"It is an honor to be selected the 
next chancellor of Washington 
University. I am mindful of the trust 
placed in me, and I pledge to do my 
very best to demonstrate that the 
confidence in me is well-placed," 
sa id Wrighton on the occasion of 
being named chancellor. "Succeed ­
ing Bill Danforth as chancellor is a 
special privilege, and I look forw ard 
to his wise counsel in the years 
ahead." 
Mark S. Wrighton, Ph.D. 
Danforth congratulated the 
search committee "fo r finding 
and selecting someone of Mark 
Wrighton's excellent qualificatio ns ," 
saying that Wrighton "is a wonderful 
choice whose experience with 
facu lty, students, staff, trustees, 
alumni and friends at MIT will serve 
Washington University well." 
Wrighton has been provost at 
MIT since 1990, overseeing the 
institution's $1.1 billion budget and 
coordinating the five-year planning 
process. He headed MIT's educatio n 
and resea rch programs, and he has 
emphasized the value of teaching in 
a research uni vers ity and the 
strengthen ing of undergraduate 
education. Wrighton led efforts to 
expand environmental education 
and research programs and worked to 
build diversity within the faculty. 
He joined the MIT 
faculty in 1972 and became 
a full ptofessor at the 
unusually young age of 28. 
Considered one of the 
nation's leading young 
scientists, Wrighton holds 
14 patents. Within his field 
of chemistry, he explored 
ways to mimic the photosyn­
thesis of plants and to tailor 
the optical, wetting and 
catalytic properties of 
surfaces. He earned a B.S. 
in chemistry from Flo rida 
State University, then went 
on to California Institute 
of Technology where he 
completed his doctorate in 
chemistry at the age of 22. 
An outstanding teacher, 
he has received prizes for 
both graduate-level and 
undergraduate teaching at 
MIT. He also is recognized 
for his public service to 
government, serving the Air 
Force Office of Scientific 
Research, Sandia Laborato­
ries, Department of Energy, 
Oak Ridge National Laboratories, 
National Science Foundation, 
National Research Council and 
other bodies. 
Wrighton, now divorced, has 
two children, James, 17, and 
Rebecca, 14, both of whom attend 
school in Boston.• 
Editor's note: A more complete 
article about Chancellor Wrighton 


































































THE School of Medicine will playa lead ing role in estab­lishing a regional center to 
train healthcare professionals to 
detect, treat and prevent sexually 
trans mitted diseases . 
The St. Louis STD/HIV 
Prevention Training Center is 
funded by a five -year $2.1 million 
grant from the federal Centers for 
Disease Control and Prevention in 
Atlanta. The grant was awarded to 
the St. Louis County Department 
of Health, in partnership with the 
School of Medicine and the City 
of St. Louis Department of Health 
and Hospitals. 
The School of Medicine 
will receive $1.48 million of the 
grant to establish and maintain 
training center operations, says 
Bradley Stoner, MD., Ph.D., 
assistant professor of medicine and 
anthropology, and the project's 
medical director. 
Nine other U.S. sites were 
selected to offer regional training 
centers as part of a federal program 
to slow the rise in sexually transmit­
ted diseases such as AIDS and 
syphilis. The St. Louis center will 
serve healthcare workers in Missouri, 
Iowa, Nebraska and Kansas. 
"This is an outstanding opportu­
nity for Washington University 
faculty to serve as experts in STD/ 
HIV training," Stoner said. "It 
certainly raises the visibility of 
the School of Medicine and the 
St. Louis area as an important 
national site for STD training and 
research. We hope that the center 
serves to raise awareness of the 
importance of STDs as a major 
public health threat. " 
The local project also will 
involve the University of Missouri­
St. Louis and St. Louis University. 
Training courses will begin in 1996.• 
Chris Garner, a student at Kirkwood High School, Is Interviewed by 
Channel 4 News as he leaves a workshop sponsored by the medical 
school's Students Teaching AIDS to Students (STATS) program. At the 
workshop, held In March, Gamer and other student leaders from 70 area 
high schools discussed HIV biology, transmission, prevention and poten­
tial treatment strategies. The goal of the program Is to encourage the 
students to Implement AIDS awareness projects In their communities. 
Any Innovative Ideas? 
THE BJC Health System is 
offering grants for projects 
that investigate ways to 

improve healthcare within the B]C 
system through a new program 
called the B]C Innovations in 
Healthcare Program. 
The program will consider 
projects designed to improve 
coordination of clinical services, to 
test innovative approaches to 
patient care (including new 
therap ies or diagnostic procedures) 
or to increase the efficiency of 
system operations by improving 
quality or lowering costs. It is open 
to all B]C employees as well as 
School of Medicine faculty and staff 
involved with clinical operations 
at BJC. 
Those interested in applying for 
grants must obtain an application 
packet and submit a proposal. A 
maximum of $20,000 will be 
awarded for individual projects. 
Projects must be completed within 
18 months. 
Applications are reviewed based 
on the following standards: 
• The proposed project should 
be consistent with the goal of the 
program, which is to improve the 
value of BJe's healthcare delivery. 
• There should be scientific 
validity to the study (a clearly 
defined project with a measurable 
outcome). 
• Innovative change should 
be the goa\. 
• The study should be feasible 
and have the likelihood of comple­
tion or implementation at B]C. • 
' 1995 Outlook, Summer 1995 5 
RES EAR 
A New Concept In Brain Surgery 
MRI images show the position of a rice grain-sized magnet (pink dot) which 
carries medications or sources of radiation through the brain. Surgeons use the 
images to plan brain surgery and navigate through the brain. 
THE School of Medicine has entered into an agreement with Stereotaxis Inc . to test a 
computer-controlled magnetic 
system for delivering therapeutic 
agents to the brain. 
"This technology will be a 
minimally invasive, more efficient 
and safer way of doing brain sur­
gery," says Ralph G. Dacey Jr. , M.D., 
professor and head of neurologica l 
surgery. Dacey will direct the 
research team, which will include 
collaborators from the University 
of Iowa, the Medical College of 
Virginia and the University 
of Washington. 
The Magnetic Stereotaxis System 
(MSS) should improve treatments 
for brain tumors, Parkinson's disease 
and other neurologic disorders. The 
technology is being tested in gel 
models of the brain and should be 
ready for human trials in 12 to 18 
months. Stereotaxis holds exclusive 
wo rldwide patent rights. 
The major advantage of the 
magnetic system is that it will allow 
neurosurgeons to move precise ly 
through the brain in any direction, 
avoiding sensitive areas that may lie 
between the surface and the area to 
be treated. Non- linear movement is 
possible because magnetic fields 
gu ide a rice grain-sized magnet that 
pulls a small implant containing 
drugs or sources of radiation. 
The research will focus initially 
on improving treatments for malig­
nant brain tumors. 
Magnetic tumor surgery will 
allow a Oexible radioactive catheter 
to be coiled into the tumor so that 
gamma rays can kill the tumor cells. 
The insertion will take one to two 
hours and potentially could be 
performed on an outpatient basis. 
The patient will return a few days 
la ter to have the implant magneti­
cally removed. 
BJC Health System will support 
the resea rch and house the device in 
Barnes Hosp ital. • 
C H 

A New And 
Improved PSA 
ANEW version of a common screening test for prostate cancer can more accurately 
pred ict wh ich patients have cancer, 
according to a study by School of 
Medicine researchers. The updated 
test should enable many men with 
benign prostate conditions - for 
whom the traditional screening test 
often incorrectly indicates cancer­
to avoid unnecessary follow-up 
biopsies. 
The test can reduce up to 75 
percent of unnecessa ry biopsies and 
still detect 90 percent of prostate 
cancers, says lead investigator 
William J. Catalona, M.D., urologic 
surgeon and head of the division of 
urologic surgery. 
The new test, which is still 
experimental, may ultimately prove 
to be a major cost sav ings. A 
prostate biopsy costs about $1,200. 
The traditional prostate cancer 
screening test detects total blood 
levels of prostate-specific antigen 
(PSA), a protein produced by the 
prostate. Elevated leve ls are a 
poss ible indicator of cancer, which 
then must be confirmed by biopsy. 
Critics of the PSA test point to 
its high rate of false positives. For 
every three men with elevated PSA 
levels who undergo a follow-up 
biopsy, only one patient is found to 
have cancer. A non-cancerous 
condition called benign prostatic 
hyperplasia (BPH), commonly found 
in olde r men, can also cause PSA 
leve ls to rise. 
The new test better distin­
guishes between men with prostate 
cancer and those with BPH, the 
researchers found. The test measures 
blood levels of a free-Ooating form of 
PSA. For unknown reasons, men 
with prostate cancer have signifi­
cantly lower levels of this "free" PSA 
compared to men with BPH, says 
Catalona, who pioneered PSA 
testing for prostate cancer. • 


































FDA OKs Herpes 
Test 
ANEW diagnostic test for the herpes simplex virus, devel­oped at the School of 
Medicine, has been approved by the 
federal Food and Drug Administra­
tion. The new test is faster and easier 
to use than current diagnostic tests 
for the herpes virus. 
Genital herpes is one of the 
most common sexually transmitted 
diseases in the world. Up to 500,000 
Americans are newly infected with 
genital herpes every year. The test 
detects both herpes simplex virus 
Type 2, which typically causes 
genital herpes, and herpes simplex 
virus Type 1, which is most com­
monly associated with cold sores on 
the face and mouth. 
The test was developed by Paul 
Olivo, M.D., Ph.D., an assistant 
professor of medicine and molecular 
microbiology. The test was licensed 
in 1994 to Diagnostic Hybrids Inc., a 
company in Athens OH. FDA 
approval gives Diagnostic Hybrids 
the go-ahead to commercially 
market the test. 
The new test takes up to 18 
hours to get conclusive results, 
compared with the gold-standard 
herpes test which can take up to a 
week. The test's speed helps ensure 
that patients infected with the virus 
will receive effective treatment 
quickly. 
It also will enable physicians to 
confirm a herpes diagnosis faster and 
will be especially important in the 
quick diagnosis of neonatal herpes 
infection. 
The new test theoretically could 
be modified to detect any type of 
virus and may be used to identify 
patients who have developed drug­
resistant herpes infections.• 
EAR C H 
A Dark Side To Neurotrophins 
NERVE growth factors promote the survival and differentiation of neurons, 
but certain growth factors, called 
neurotrophins, have a sinister side to 
their nature and can cause nerve 
cells to die. 
The finding raises a cautionary 
note about the potential use of 
neurotrophins against brain disorders 
such as Alzheimer's disease, 
Parkinson's disease and stroke, says 
Dennis W . Choi, M.D., Ph.D., Jones 
Professor and head of neurology, 
who led the study. 
Cultured mouse neurons die if 
they are briefly deprived of oxygen 
and glucose. These conditions mimic 
ischemic stroke, in which a clot 
stops blood flow to a region of the 
brain, cutting off the supply of these 
essential substances. But more 
cultured cells died when a 
neurotrophin was present, the 
researchers found. A day after the 
deprivation, fewer than 20 percent 
of the control cells were dead, but 
about 50 percent of the cells exposed 
to a neurotrophin had diSintegrated. 
Discovering how the factors 
sabotage cells will be an essential first 
step toward explaining the results. 
Neurotrophins enhance necrosis via a 
glutamate receptor called the NMDA 
receptor. When an antagonist called 
MK-80 1 occupied these receptors, 
calcium ions did not invade the 
neurons, and the factors were no 
longer harmful. But antagonists of 
other types of glutamate receptors 
were not protective. 
The researchers tried all four 
known neurotrophins in these 
experiments.• 
No Two Chest Pains Are The Same 

DOCTORS treating patients with chest pain need 
to pay more attention 
to how bothered 
patients are by their 
symptoms, says Robert 
Nease, Ph.D., assistant 
professor of medicine. 
Results of a study Nease 
conducted show that 
attitudes about pain vary 
substantially, even among 
patients with similar 
severities of angina, or 
chest pain, caused by 
heart disease. 
Nease says 
standard guidelines for 
treating angina are 
primarily based on 
objective measure­
ments of disease 
severity. However, 
those guidelines do not 
take into account how 
patients feel about their 
symptoms of pain and discomfort. 

"We found that some 

individuals are much more 

bothered by their pain than 
others - even among 
patients with similar levels 
of symptoms," Nease says. 
"Guidelines are often silent 
about the importance of 
the preferences of the 
individual patient." 
One of the main 
benefits of treatment 
for angina is to reduce 
pain and discomfort. 
So, finding the best 
treatment should 
depend, in part, on 
how bothered each 
patient is by his or her 
symptoms, he says. 
"Good decision­

making should respect both 

the best available scientific 

information and the 
preferences of the indi­
vidual patient," he says.•~ ..... 
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Study shows cochlear 
implants help the 
profoundly deaf learn 
language skills faster, 
better. 
by Juli Leistner 
Our(( 
I n classroom after classroom at Central Institute for the Deaf, small groups of children sit face to face with their teachers, being taught a skill that very few profoundly deaf children have the 
opportunity to learn: how to speak. 
In most ways, this school is like any other 
elementary school; classrooms and hallways show# 
case colorful children's art, students expend bound# 
less energy in the kid#sized gymnasium, and, outside 
of class, children laugh and talk with friends. 
Out/oak, Summer 1995 
But there are a few differences. 
Central Institute for the Deaf (CID) is 
one of about two dozen schools in the 
country where deaf children are taught 
to speak. Because profound ly deaf 
children cannot hear what speech 
sounds like, they do not learn to ta lk 
the same way normal-hearing children 
learn - by mimicking the sounds of 
o thers. Instead, they need years of 
specialized, one-on-one tra ining, 
which CID provides. 
The Institute's 100 students, 
ages three to 15, are immersed in an 
environment focused on speech. Most 
classes have only two o r three children 
who receive indiv idualized instruction 
sitting at small tables with their 
teachers. The students learn the same 
subjects that other children their age 
learn, but, in addi tion, they spend 










"Learning to talk is very hard 
work for these children," says Jean 
Moog, M.S., principal of the nation­
a lly recognized schooL "But even the 
younges t ones are eager to learn and 
are willing to work hard." 
Recently, Moog and Ann Geers, 
Ph.D., both associate professo rs in the 
University's Department of Speech 
and Hearing, found a way that may 
help the most profoundly deaf children 
learn language skills faster and be tter. 
They conducted a study eva lua ting the 
benefits of cochlear implants, h earing 
devices deSigned for the profoundly 
deaf, and compared them to other 
sensory aids in 39 profoundly deaf 
ch ildren. 
The researchers followed the 
progress of the children for three years 
as they learned language sk ills and 
found that those with cochlear 
implants understood speech better, 
spoke more clearly and used speech 
more often to communicate than 
children who llsed other types of 
senso ry aids. 
"Coch lear implants seem to 
provide a dramatic advan tage in 
he lping these children learn to speak 
and understand spoken language," says 
Geers, directo r of ClD's clinical 
se rvices and principal investigato r of 
the study. "These results are important 
to us because the ability to talk opens 
up options - social, voca tional and 
intellectual- that these children do 
not have if they don't share a language 
with their culture." 
Nationwide , on ly about 10 
percent of profound ly deaf children 
learn to speak, largely because of lack 
of access to the specialized training 
required. 
!I 
CID instructor Terri O'Donoghue works with four-year-olds David Browning and Danielle Hinton during speech class. 








Alison Cohn and Ryan Slattery, both age four, listen as Jean Moog, M.S., principal of CID, explains an art project. 	 s 
a 
The researchers say they were 
interested in cochlear implants as a 
way to make the learning process 
easier for the school's most profoundly 
deaf students. These children get little 
or no benefit from conventional 
hearing aids - precise ly the type of 
person cochlear implants are designed 
to help. 
A cochlear implant has an 
internal unit that is surgicall y im­
planted into the inner ear. With the 
help of an external microphone and a 
sound processor, the device directly 
stimulates the auditory nerve to 
provide sound. "We reasoned that a 
device that could improve access to 
sound for our profoundly deaf children 
would provide an opportunity to get 
them talking earlier," Geers explains. 
Children in the study represented 
the deafest segment of the population. 
Some had complete hearing loss, while 
others needed the help of an aid to 
detect sounds of 100 decibels, a sound 
about as loud as a lawn mower at close 
range. The children's ages ranged from 
two to 10 years at the beginning of the 
study, with an average age of about 
five and one-half years. 
All 39 children in the study 
previously had worn conventional 
hearing aids. For the study, 13 children 
received a cochlear implant; 13 
continued to wear their conventional 
hearing aid, and 13 others wore their 
conventional aid plus a tactile aid, a 
device that transmits sound as vibra­
tion on the skin. 
"After we got into the study, we 
saw that the children with cochlear 
implants were doing remarkably well 
and that comparing them to other 
children with similar hearing loss 
would not be stringent enough," Geers 
says. For an extra comparison, the 
researchers collected data from 13 a 
children with slightly less severe 
hearing loss . This "hearing aid plus" II 
group wore hearing aids but gained U 
substantially more benefit from them j 
than children in the original study c 
groups. 
Dramatic Advantage 
All of the children in the study 
progressed, but cochlear implants 
offe red several advantages, including c 
enhancing the ability to hear speech 
sounds. 
Using a series of interactive tests u 
designed at CID, the researchers rated 
each child's ability to hear speech. At 
the beginning of the study, most of the 
children could hear basic speech 
patterns - the difference between a s 
uone-syllable and a two-syllable word. 
t. But none could make more difficult 
" distinctions, such as telling the 




would expect them 
all to hover around 
the same percenti Ie 
over time ," Geers 
says. 
, 
But by the end of 
the study, implant 
wearers had jumped 
to the 85th percen­
tile in standard ized 
tests, while tactile aid 
wearers scored in the 
70th percentile and 
hearing aid wearers 
were still in the 55th 
Jean Moog and Ann Geers, Ph.D., both associate percen ti Ie. 
professors in the University's Department of Speech Implants not 
and Hearing, found that cochlear implants help only helped children 
profoundly deaf children speak more clearly and understand speech, 
understand speech better than other hearing devices. but helped them 
difference between words with similar 
stress patterns (airplane and tooth­
brush), or harder still, distinguishing 
between words that differ only in the 
vowel (boat and boot). 
By the end of the study, most 
hearing aid and tactile aid wearers had 
not progressed much beyond their 
initial ability to hear speech patterns. 
By contrast, most cochlear implant 
wearers could distinguish between 
similar words, such as bea r and pear, 
and were the on ly group that could 
identify spoken words without having 
a set of words to choose from. 
Implants also helped children deal 
with the more true-to-life test of 
understanding conversational speech. 
All profoundly deaf children rely on a 
combination of lip reading and 
listening to understand speech, Geers 
explains; this study showed that 
implants helped children get more 
information from a speaker's voice. At 
the end of the study, most children 
could understand about 56 percent of a 
spoken message by observation alone. 
But with sound added, implant wearers 
understood an add itional 12 percent of 
the message. 
Implant wearers did far better 
than expected for their ages. Accord­
ing to standardized tests, the children 
started out with average abilities to 
understand spoken language compared 
to o ther deaf children the ir own age. 
"If they were to develop normally, we 
Ie 
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produce better 
speec h as well. "Their voices have 
more intonation, and their vowel 
sounds and consonants are more on 
target," says Moog. "The implants 
a llow them to hear as they learn, 
rather than learning to speak just from 
visual cues. " 
Children with implants also were 
more communicative. By studying the 
younger children during play sess ions 
with their mothers, researchers saw 
that implant wearers initiated commu­
nication more frequently, and they 
communicated more often with speech 
as opposed to gesturing or touching 
their mothers. 
Overall, cochlear implants seem 
to make the learning process easier. 
"The children with implan ts get less 
tired and seem to learn with less 
effort," Moog says. 
An Edge In The Classroom 
The researchers say cochlear implants 
could have a big impact in the 
classroom. One reason: Helping deaf 
children learn spoken language will 
help them learn to read. As Moog 
explains, normal -heari ng children 
become familiar with the basics of 
English structure and grammar when 
they learn to speak. With that knowl­
edge base in place , making the 
transition to reading is rela tive ly easy. 
But deaf children who do not learn to 
speak may not acquire this know ledge 
base. 
"Many people think that reading 
should not be a problem for deaf 
people because their eyes are nOt 
affected . But haVing a command of 
English syntax and vocabulary are 
critical factors in learning to read," 
Moog says. "Hav ing a spoken English 
base greatly facilitates learning to 
read. " 
Deaf children who learn to speak 
generally end up able to read at a 
higher grade level than deaf people 
who do not learn this skill, Moog adds. 
Nationwide, deaf ad ults read at about 
the third to fifth grade level. 
As soon as CID students catch up 
to their grade level in language, speech 
and academic skills, they leave the 
program to attend school in their 
communities with normal -hearing 
peers. One of CID's goals is to help 
this mainstreaming process happen as 
quickly as possible. ClD students with 
moderate to severe hearing loss usually 
are mainstreamed during the early 
grade school years. Children with 
profound hearing loss require more 
training and typically are main­
streamed later, in the seventh or 
eighth grade. 
Cochlear implants may enable 
students to catch up sooner by helping 
them learn to read faster and better, 
Geers says. CID already is seeing this 
trend among its students who wear 
implants. About 40 percent of CID's 
students currently wear the devices. 
"We are a lready mainstreaming 
these children earlier than we would 
have without cochlear implants. So 
these devices are rea lly accelerating 
the progress in our educational 
program," Geers says. 
One of the most satisfying aspects 
of working at CID is watching graduat ­
ing students give their required speech 
at the school's graduation ceremony, 
Moog says. "When these children are 
very young, they aren't aware of what 
they are achieving. It isn't until they 
get a little older that they reali ze how 
hard they have worked and what an 
extraordinary accomplishment they 
have made," she says. "And then they 
are very proud of it." • 
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"At present, phys icians don't have 
a good way of assess ing the brain' s 
response to treatments for neurological 
damage - we're working with a black 
box," says Michael N. Diringer, M.D., 
ass istan t professor of neurology , 
neurosurgery and anesthesiology. In 
1992 , Diringer became directo r of 
Barnes Hospital's neurointensive care 
unit. "I left Johns Hopkins because of 
this scanner," he says. "The opportu­
nit y to do thi s work seemed so 
unique. 
The proj ect is distinguished by 
the logist ical challenges posed by PET 
and ve ry ill patients. PET scanners 
cos t about $2 million and requ ire 
fac il i ti es for generati ng rad ioacti ve 
isotopes. But Washington University 
has a long histo ry of PET research ­
the first usable scanner was deve loped 
by Michel M. T er-Pogoss ian and 
co lleagues at the University's 
Mallinckrodt Institute of Radiology 
in the early 1970s. "Our ab ility to do 
this research reflects a happy coinci­
dence ofWashll1gton Univers ity's 
prev io lls histo ry of PET resea rch 
and its infrastructure," says Dennis W. 
C hoi , M.D., Ph.D., Jones Professor 
of neurology. 
Funds from the Nationa l Insti­
tutes of Health, Barnes Hospi tal, 
Washington University's McDonnell 
Michael N. Diringer, M.D., assistant professor of neurology andCenter for Higher Brain Function and 
neurosurgery and director of Barnes Hospital's neurointensive care unit, the departments of Neurology, 
checks on a patient who suffered a head injury. N euro logical Surgery and Radiology 
were used to purchase the scanner, 
which can image the entire brain. 
"The PET scanner will allow us to 
mo re fully understand situations in 
which acute bra in injury occurs, either 
as a resu lt of physical trauma, such as 
an auto accident, o r after stroke 
involving ruptured blood vessels. 
Learning more about these conditions 
will, in turn, help us to take better 
care of our patients," says Ralph G. 
Dacey Jr., M.D. , professor and head of 
neuro log ical surgery. 
"It was obvious to everyone 
concerned that there was a lo t to be 
learned from PET," adds Choi, who 
also is head of neurology. "We now 
have reached the point where the goal 
of treating the acutely injured human 
brain is in sight. The scanner will 
provide a pipeline between molecular 
and cellular advances and improve­
ments in clinical care." 
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images to be o btained during the 
critical first hours after brain injury, 
when most of the damage occurs. 
"Other types of studies have looked at 
pati ents a few days after a stroke or 
head injury, " Diringer says. "But we 
want to look within six hours, when 
there is a window of opportuni ty for 
intervention. " 
By generating images of blood 
flow and oxygen use in different parts 
of the brain, PET can revea l whether 
an injured region is rece iving and 
consuming nutrients and oxygen. "It is 
the only way to measure how much 
oxygen a particular part of the brain is 
using," Powers says. "It can tell you 
which parts of the brain are getting as 
much as they need and which parts are 
barely hanging on. So it is absolutely 
the most direct way to figure out what 
is happening. " 
Barnes Hospital is directing this 
pipeline to its patients. "This research 
will be instrumental in enhanCing our 
ability to improve the outcome fo r 
patients with stroke or other acute 
brain injuries" says Jennifer Fallert, 
the hospital's neuroclinical se rvice 
line director. "It will allow us to 
evaluate and improve our therapeutic 
options." One thousand patients enter 
the hospital's neurointensive ca re 
unit each year, and nearly half have 
these conditions. 
The research requires a scanner in 
a neurointensive care unit because 
subjects must rece ive constant and 
specialized care. The neuroi ntensive 
care unit provides the most sophisti­
cated monitoring equipment available. 
When it was built in 1992, Barnes 
Hospital set aside space for the 
scanner. The arrangement allows 
13 
William J. Powers, M.D., associate professor of neurology and neurological 
surgery, peers through the PET scanner used to image the entire brains of 
persons who have suffered acute brain injury. 
Current Treatments: 
Helpful Or Harmful? 
The research, which began inJune 
1995, initially will focu s on how to 
help the brain heal itself. Two studies 
will document the changes that occur 
in the brain after head inj ury o r 
intracerebral hemorrhage, in which 
patients with high blood pressure have 
bleeding into the brain. Clinicians 
who treat such conditions lack a very 
basic piece of information - whether 
damaged regions of the brain run short 
of oxygen as they do in ischemic 
stroke, where a clot cuts off blood fl ow 
to the brain . "If we find that to be 
true, we can apply drugs that are be ing 
tried for ischemic stroke ro thi s patient 
populati on," Oiringer explains. "Right 
now this is a big issue. " 
A third study will examine the 
controversia l practice of treating 
hypertension in patients with intra­
cerebral hemorrhage. "Blood pressure 
ri ses when people hemorrhage into the 
brain," Powers explains. "But if you 
ca lled three neurologists, you would 
ge t three different opinions about how 
to respond. Some say you should leave 
blood pressure alone; others say you 
should bring it down a bit, and o thers 
say you should bring it down a lot." 
The confusion arises because , 
while high blood pressure can damage 
t he heart and kidneys, lowe ring blood 
p ressure may reduce the supply of 
oxygen to the brain, "which is the las t 
thing an injured brain wa nts," says 
Powers. But the PET study will 
mo nitor injured parts o f the bra in as 
blood pressure is gradua ll y lowe red. 
"This is a problem we face day in and 
day out , and we agonize ove r it ," 
Diringer says . "So we would like some 
guidance." 
Patients with suba rac hno id 
hemorrhage - the type of stroke th at 
killed Lillian Strauss - often are gi ven 
drugs to raise the ir blood p ressure. 
These patients bleed into the bra in 
through a burst aneurysm, and th e if 
blood vessels often go in to spasm. 
Drugs that force blood through those 
vessels by rais ing blood pressure ca n be 
damaging to the h eart, so a PET study 
will determine whether less harmful 
drugs also can be effecti ve. More 
aggress ive trea tments, such as 
angioplasty and intra-arte ria l papaver­
ine, which are now be ing offered to 
these stroke patients, a lso will be 
examined. 
H yperventila tion is a technique 
used on head injury patients to contro l 
pressure inside the head . "But there is a 
big controversy ove r whethe r h ype r­
ventilation is harmful o r helpful," 
Diringer says, "because the blood fl ow 
to injured parts o f the bra in may be 
critically reduced" PET images before 
and during hyperventilation will show 
whether blood fl ow becomes so slow 
that it places the brain at risk for 
furthe r damage. 
limiting Damage 
These projec ts should narrow a 
majo r gap in our understanding o f 
bra in injury and the brain's response 
ro current treatments. But plans to 
limit brain injury are also in progress. 
The Center fo r the Study of Nervous 
System Inju ry , headed by Choi , 
will test compounds that might 
pro tect the injured brain from damage 
by a neurotransmitter called glutamate , 
which no rma 11 y is released in 
di screte amounts during cell to cell 
communication. 
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When a neuron runs sho rt of oxygen, 
it releases its entire stock of glutamate, 
overexc iting receptors on nearby cells. 
Beca use these recepto rs a re io n 
channe ls, they let in deCld ly amounts 
of sodium and calciu m ions. Bm if 
pa ti e nts could receive a drug to bloc k 
the receptors, damage might be 
curtailed. "Drs. Powe rs, Diringer and 
colleagues will lise the scanner co 
guide the appli C<1tio n of new 
neu roprotective str;)tegies - fo r 
exa mple, by identifying patients who 
have brain ti ss ue in jeopardy and could 
benefIt from a neuropro tective 
treatlllent," C ho i Sell'S. 
The PET studi es will not repl ace 
c linica l tri a ls which tes t new th e rapie~ 
un thousands of p;)t ients. Bm they will 
he lp de termine wh ich new trea tments 
or drug, may be worth eva lu ating. "We 
will be ab le to gi ve the rapy X and 
immed iately ge t a much better 
understanding of whethe r that therapy 
is do ing what we want it to do ," 
Diringe r says. "So this approach 
provides an inte rmediate ,;Lep between 
basic research a nd clinical tri a ls. " 
T es ting these ideas will req uire 
funds to pay technicians, maintain a 
se rvice contract , genera te radioact ive 
iso topes and suppo rt tim e-consuming 
da ta ana lysis. When the resea rche rs 
have suffic ient data, they wil l apply for 
gran ts to support ongo ing resea rch. 
Funds from the N ationa l S troke 
Assoc iation, the McDon ne ll Center 
fo r Higher Brai n Function and the 
Lillian Strauss Fund are supporting the 
pre lim inary studi es. 
Malco lm Strauss a nd hi s two 
daughters, S tephani e S huchart and 
Sand ra Lyn n Birenbaum, estab lished 
the Lillian Strauss Fund in 1974. Then 
for several yea rs, they o rganized Labor 
Day bowl ing contests at Str ike 'N 
Spare Lanes in Creve Coeur to ra ise 
addit iona l contributions . They ho pe 
doc tors wi II o ne day be ab le to save 
st ro ke patients and know how to 
detect aneurysms before they burst. 
"An a neurys m took away my wife and 
my daughters' mother ," St rauss says. 
"So we wan t to stop strokes in time to 





Ischemic Strolce: The most 
common type of stroke (80 
percent of cases). Occurs when a 
hlood clot plugs either an artery 
in the brain or an artery in the 
neck that carries blood to the 
brain. The clot may form in the 
hrain itself or may travel to the 
brain from another part of the 
body. 
Hemorrhagic Stroke: 
Bleeding into the hrain caused 
by either high blood pressure 
( in tracerebral hemorrhage) or 
the rupture of a weak-walled 
blood vessel (subarachnoid 
hemorrhage). 
Illustrations by Chris Callan 
Symptoms Of Strolce: 
• 	 One-sided weakness, 
numbness or paralysis 
• 	 Blurred vision 
• 	 Prohlems speaking or 
understanding 
• 	 Dizziness or loss of balance 
• 	 Sudden, severe headache 
ublic RmaTeness: 
A recent survey by the Ameri­
can Heart Association found 
that Americans are dangerously 
ignorant about stroke: 
Almost half of those sur­
veyed did not know a single 
warning sign of a stroke 
• 	 Only 29 percent said they 
would go to an emergency 
room or call 911 if they 
experienced dizziness and 
loss of vision in one eye for 
more than 15 minutes 
The Rftermath Of 
Strolce: 
• 	 Stroke is the leading cause c' 
serious disability in the 
United States 
• 	 Stroke accounts for half of 
all patients hospitalized for 
acute neurological disease 
• 	 About one-third of stroke 
survivors die within the yeaL 
following the event 
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Disorder Takes On A 

Life Of Its Own 

ne summer day about three years 
ago, Carralee Mew took a drive 
to Lake Carlyle to see her father, 
who was camping. Shortly after she got on 
the road, she met an ambulance headed in 
the opposite direction.'Oh, my God. I've 
caused an accident,' she thought. She 
turned her car around and followed the 
emergency veh icle to witness the damage 
she had caused, but there was none ; there 
was no accident. 
Mew met two more ambu lances that 
day, and each time she felt compelled to 
turn her vehicle around to go to the scene 
of what she feared was a deadly automo­
bile accident that she had caused . Both 
times she was wrong. 
What should have been a 45-minute 
jaunt to see her father turned into an 
exhaus t ing three-hour o rdeal. "I always 
think that I'm going to cause catastrophe," 
says Mew, a 54-year-old St. Louisan who 
has obsessive compulsive disorder, or 
OCD. "I would have to go over and over 
and over things in my mind - I was 
always checking." 
Mezo's disturbing and difficult-to­
dismiss thoughts, as we ll as the repetitive 
behaviors she perfo rmed in response to her 
thoughts, are typical of people with OCD, 
says Elliot Nelson, M.D., assistant profes­
sor of psychiatry who studies the disorder. 
"People with anxiety disorders such as 
OCD have difficulty with some of the most 
basic aspects of life that we all take for 
granted," says Nelson. "They don't have 
voluntary control over their own thoughts. 
Thoughts pop into their head and persist 
to the point of becoming intrusive; their 
thoughts almost have a life of their own." 
The most common types of obsessive 
thoughts are worries over dirt or germs and 
those which involve harm, either to the 
person with OCD or to o thers. Compul­
sions that occur in response to these 
thoughts include washing behaviors and 
checking rituals such as checking the door 
lock and making sure the iron or stove is 
turned off, Nelson says. 
Other obsessions and compulsions 
that are fairly common but less talked 
about can be frightening when they occur, 
Nelson says, because they involve thoughts 
of causing harm to family members. 
Mezo says the thought that most 
haunted her was that she either had killed 
or was about to kill someone. The first 
time such a thought came over her was 
when she was 23 and her eldest daughter 
was three. 
by Kleila Carlson 
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At one point in her life, Carralee Mezo lived in constant fear she was going to 
poison someone if she offered them a cup of coffee. 
"[ love my daughter more than 
life, but one day she walked through 
the living room, and [ saw her, and [ 
saw a knife," Mezo recalls, the disbelief 
still apparent 111 her voice. "[ became 
frozen with fear that [ was going to kill 
her, but I couldn't understand why I 
would want to kill this child who was 
my life, that I loved so much." 
After 12 months o f therapy , M ezo 
still had no answers. She was adv ised 
by mental health experts to "keep 
busy," which she did for the n ext 28 
years. She had another child (a 
daughter), went to beauty schoo l and 
became a beauty schoo l teacher, 
joined the Junior Women's Club, was 
a Brownie co-leader, coached a 
volleyball team, owned two successful 
beauty salons and was known fo r her 
lavish sit-down dinners. 
"[ had a really full life," says Mezo , 
who began recei v ing rreatment three 
years ago. "I've always been a very 
determined person, so I conv inced 
myself that whatever it was that I h ad, 
I could get over. But [just masked it; it 
was a lways there , underlying." 
Mezo began to live in co nstant 
fe ar that she was go ing to po ison 
someone , At her fir st bea uty sa lon, 
which sh e owned fo r about 15 years, 
coffee was a lways brewing, but Mezo 
hes ita ted to o ffer it for fe ar she would 
kill h er customers, "1 wouldn't let 
them drink a full cup of coffee," she 
says. "O nce I saw th at a customer had 
a few sips, I would say 'that's enough,' 
a nd take the cu p. Then, I'd keep what 
they hadn't drunk for a day or two so it 
could be ana lyzed to prove that I 
hadn 't po isoned them in case some­
thing happened. " 
She a lso agonized when left alone 
with sma ll children and infants. Once, 
while a t the drug store to purchase 
h ouseho ld supplies, she was certain 
that she h ad po isoned a toddler she 
came upon in a deserted ai sle. The 
toddler , who was toting a bottle in her 
mouth , began foll owing Mezo down 
the a isle. Mezo, who had a bottle of 
liquid Wisk in her ca rt, broke out into 
a swea t, dashed to the checkout 
counter to pay fo r he r items and ran to 
her ca r. A ll the way home, she tri ed to 
te ll herself that she had not taken tl1e 
child's hottl e o f milk, o pened it and 
poured in liquid Wisk, 
"When I gor home, I opened the 
Wisk thinking that if the a luminum 
cove r was ove r the o pening I'd know I 
didn't ge t into the bottle," she recalls. 
"I ope ned the bo ttle and the cover W,h 
gone. 'We ll, O K,' [ thought, 'there are 
32 ounces in the bo ttl e , so I'm going to 
have to ge t a meas uring cup Cl nd 
me~bure it. But I'll have to measure it 
exac tl y because it wouldn 't have taken 
ve ry much if I'd put some in that 
baby's bo ttle. '" 
A lthough sh e was able to curb her 
erra tic though" . bv exactl y measuring 
the co ntents of the \)~' i sk bottle , the 
first thing she did the nex t morning 
was look in the obitua ry section of the 
newsr ape r fo r the death of a child. 
Mezo's fe ars may seem unfathomable , 
but N e lson says millions o f Americans 
with OCD have unusual thoughts that 
linge r fo r hours or days, interfering 
with the ir way of life and li velihood. 
O nce be lie ved to he a rare 
psychiatric disorder, OCD affects 
roughly 2 to J percent of the U .S. 
population, or 5 million peorle. The 
typical age of onset is late teens to 
early 20s - sometimes a little ea rlie r 
in males than in females - and its 
cause is unknown. 
Nelson says that often, people 
with OCD seek treatment for ano the r 
illness such as depression or an xiety, 
not necessarily symptoms associ ated 
with OCD. Some 30 percent of 
individuals with OCD are depressed a t 
the time they seek treatment. 
"In genera l, people with OCD 
have good insight in to their symp­
toms," Nelson says. "They know that 
their thoughts sound kind of odd . 
They don't make sense to the OC D 
sufferer , so why would they te ll 
someone else about them? Many times 
they keep the problem to themselves 
for fear they will be emba rrassed or 
made fun of." 




Mezo told no one about her 
preoccu pying though ts, not even her 
closes t friend of 30 years. "J couldn't 
tel l her what I was thinking, that I 
though t I was going to kill somebody. 
You Jus t don't do that ," she says. 
Although OCD is well described 
in the medical literatu re going back to 
the 17th century, Ne lson says many 
people with the disorder do not realize 
th e ir unusual thoughts are ac tually a 
symptom of an illnt'ss. "Unfortunately, 
when you have a menta l illness, t here 
is no direction book," he says. "So, 
until someone hea rs about OCD or 
until we really get the word out to 
the public, some people will cont inue 
to have unusual thoughts and not 
know why." 
Psychiatry is do ing its part to 
increase awa reness by sc reening more 
for the illness than it has in the pas t. 
Using positron emiss ion tomography 
(PET) to measure brain act ivity, 
researchers h ave homed in on twO 
areas of the brain that appea r to be 
in vo lved in the illness: the front a l 
lobes, par ticularly the o rbital frontal 
cortex around the eyes, and the basa l 
gangli a, an area which is invo lved in 
se lecting actions or putting act ions 
together, Ne lson says. 
Resea rch suggests the neurotrans­
mitter sero tonin plays a ro le in the 
illness. All of the medica tions that are 
effect ive in treating the disorder a lter 
the level o f this neuro transmitter in 
the brain, Nelson says. 
Ne lson, who studies po tentia l drug 
therapies for OCD as well as va rious 
neuropsychologica l tests, a lso is 
interested in the gene tic aspec ts of the 
d isease. He plans to do a linkage study 
by looking at families who have 
multiple members with OCD. C ur­
rently, he is examining childhood­
onse t OCD patients who were initia ll y 
trea ted at Children's Hospital. 
"There's an increased rate of OCD 
among first-degree family members 
(parents and children) somewhere in 
the neighborhood of 10 to 15 percent," 
he says. "There's also an increased rate 
among monozygo ti c (identi ca l) twins . 
If one twin has the illness, then 
approximately 60 pe rcent of the co­
twins have the illness. " 
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yea rs - the one she was afra id to 
confide in - who told her she Depending on the seve rity of the 
suspected Mew was suffering from disc;lse, Ne lson says treatment may 
obsess i ve compu lsi ve disorder and 
require behav ior therapy, medication 
encoumgeJ her to seek treatment. 
o r a combination of th e two. He says it 
Until that time, Mew had neve ris sa fest to begi n with beha vior therapy 
heard of OCD. Since then, her two 
as opposed to medication, particula rl y 
daugh ters ha ve been di agnosed wi th
when dealing with children. Behav io r 
the disorder.therapy invo lves basic relaxation 
"My goal now is to do anything I 
techniques and gradually prepares 
can for thi s diso rder because I've me t patients to confront their thought/ 
people, ('specially o lder women, whobehav io r problem by putting them in 
are ridden wi th thi s illness," says Mew. 
situations that spark the obsessive 
''The ir who le li ves were not fulfill ed as 
thoughts. Over time , and by regularly 
they could have been because they
confronting situations that spur the 
were no t diagnosed o r prope rl y treated.
thoughts, anx ie ty should lessen to the 
And trea tment is so simple, but it's a point that patients have no obsess ions, 
lo t o f work." h e says. 
Mezo, who works full time, a lso When patients participate full y in 
attends co llege and is studying behavior the rapy, Ne lson says there is 
psychology. A cand id spokesperson
significant improvement - up to 60 
who wants to demys tify a cripplingpe rce nt. He also encourages pat ients 
anxiety disorder, she regu la rly speaks 
to participa te in the OCD Founda tion, 
to second -year medica l stud ents at the 
a support group fo r people with 
School o f Medicine about OCD.
obsess ive compu lsive diso rder and 
") sometimes think of the things )
the ir friends that he started fi ve years 
could have done with my life had this 
ago. The group meets regularl y a t 
di sorder no t man ipu lated me as it did," Barnes Hospita l. 
says Mezo , who now takes medica tion 
"It can be incredibly reassuring fo r 
and can reason her harmfu l thoughts
them to know someone e lse has similar 
away. "Because ) suffered so need lessly, 
symptoms and to see that others who 
and) know there are others out therehave the illness have done well with 
suffering too, tha t's why every effort I 
trea tment," he says of the support 
have is given to thi s." • group. 
"Peop le with OCD 
fee l they are mi sunder­
stood by those around 
them who think they 
can 'just stop thinking 
about it ,'" he cont in­
ues. "They have to 
work very hard to 
challenge the ir 
thoughts and behav­
io rs, and it requires a 
great deal o f effort and 
tends to produce a 
great dea l of anx iety." 
Like Mezo , mos t 
OCD suffe rers endure 
the seem ingly bizarre 
symptoms fo r a long 
time - on average , 
seven years - before 
seeking profess iona I 
he lp. Ironica lly, it was 
Mezo's friend of 30 
Elliot Nelson, M.D., assistant professor of psychiatry, 
says obsessive compulsive disorder can cause unusual 
thoughts that linger for hours or days, interfering with a 
person's way of life and livelihood. 
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COLLABORATORS 
DELE E A KEY GENE, 
BUT HIV CONTINUES 
TO EVOLVE 
-
Alan R. Templeton, Ph.D., professor of 
biology, created genetic trees to track 
the NEF gene's course of evolution In 
the four patients studied. 
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_by Tony Fitzpatrick ne 
he prospects for a safe, Ii ve 
vaccine in the near future to 
prevent HIV, the virus that 
causes AIDS, have diminished 
with the results of an innovative 
study by Washington University 
researchers. 
Alan R. Templeton, PhD., 
professor of biology, and Lee 
Ratner, M.D., Ph.D., professor 
of medicine and molecular 
microbiology, have tracked the 
evolution of a key HIV gene in 
four patients over five years. 
They found that, even in 
instances where the gene's molecular 
sequence had evolved and mutated so 
much as to be nearly non-functional 
and unrecognizable, all of the patients 
had some intact copies of the gene, 
and the virus kept replicating. 
The gene, the negative factor 
gene (NEF), is one of the most 
important and variable genes in HIV 
which has a tiny genome (collection of 
genes) of less than a dozen genes. 
Molecular sequences are arrangements 
of four chemical units called base pairs. 
The various arrangements of base pairs 
constitute genes. 
Researchers had been hopeful that 
a live, attenuated (weakened) vaccine 
based on deleted molecular sequences 
of the NEF gene could give immunity 
to HIV by causing an immune re­
sponse in people infected with the 
weakened strain. There were encour­
aging results with a live vaccine in SIV 
(Simian immunodeficiency virus), the 
HIV counterpart in monkeys. The 
concept rests on the weakened strain 
provoking an immune response while 
being unable to replicate inside the 
body. The Sabin polio vaccine works 
on this principle. But researchers here 
say results ind icate that if a vaccine 
were to be made based on a deleted 
NEF gene, it would be unreliable 
because of HIV's ability to thrive with 
or without the NEF gene. 
Study Is A First 
The study, results of which were 
published in the April 1995 issue of 
Virology, is the first to analyze the 
evolution of the NEF gene in different 
patients over time. It combines the 
molecular biology expertise of one of 
the first researchers to sequence HIV, 
Ratner, and the population biology 
knowledge of a well-known evolution­
ary biologist, Templeton. It is repre­
sentative of many different kinds of 
collaborations between scientists at 
the Hilltop and Medical campuses, 
who are often brought together 
because of their similar, complemen­
tary backgrounds. For more than a 
decade, Walter Lewis, PhD., professor 
of biology on the Hilltop Campus, and 
H. James Wedner, M.D., associate 
professor of medicine, have worked 
together in a number of allergy studies. 
Together, they discovered that 
feverfew, a relative of ragweed that is 
abundant in the Gulf states and grows 
as far north as southern Missouri, is 
both airborne and allergenic. 
Andrew D. Dimarogonas, 
Ph.D.,William Palm Professor of 
Mechanical Design, collaborates with 
Louis V. Avioli, MD., Sydney M. and 
Stella H. Shoenberg Professor of 
Medicine and director of the division 
of bone and mineral diseases, in 
osteoporosis stud ies and analyses of 
bone strength and density. 
Dimarogonas is applying his patented 
method of vibration analysis, called 
the acoustic sweep method, to deter­
mine bone strength. 
Ratner, who has made previous 
important discoveries on how HIV 
attacks the immune system and 
disables macrophages, coordinated the 
efforts to sequence HIV for the 
National Institutes of Health (NIH) in 
1984. Templeton has done pioneering 
work in evolutionary biology and is 
perhaps best known for d ispe 11 ing the 
notion of Eve, the hypothetical 
African genetic matriarch of all 
humans, with his genetic analysis. 
Templeton used the same algorithms 
in the HIV work that he used in the 
Eve analysis. 
"HIV has such an enormous 
potential for evolution," says 
Templeton. "All of its genes are 
evolving at a tremendously rapid rate, 
making any strategy of treatment very 
difficult, because you're trying to get a 
handle on a constantly moving target. 
We wanted to monitor the evolution 
of one gene so we could speculate 
about the role it plays in the infection 
process. We wanted to see the evolu­
tionary potential of the AIDS virus 
itself throughout the infection process. 
Our results clearly show that deletion 
of the NEF gene does not prevent the 
virus from replicating and evolving 
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within the patient . I wouldn't tota lly 
rule out the notion of a live, weakened 
vaccine, but for now, I wou ldn 't want 
one pu t into me." 
Ramer, skeptical about a li ve 
vaccine from the start, considers the 
research illuminating from an evo lu ­
tionary perspec ti ve, which is the 
reason he sough t Templeton's exper­
tise in the first place. 
"We needed someone to produce 
gene rrees for NEF and explain the 
significance of their evolution, and 
A lan does this as wel l as anybody in 
the world ," says Ramer. 
Ratne r says one drawback with a 
potential live , attenuated HIV vaccine 
is the fact that HIV is a ret rovirus - it 
replicates by using ce ll machinery the 
oppos ite way that human ce lls wou ld 
use the same too ls to replicate. 
"I've neve r thought a live 
retrovirus vaccine is practical fo r 
humans, and these results support this 
I . 1 be li ef all the more," Ramer says. 
"Retrov iruses , whether attenuated or 
not, have the ability to insert their 
genetic information into our chromo­
somes forever and can express the 
vi rus at any time. T o me, an ent ity 
that inserts itself into our genome 
forever does not appear to be some­
thing you'd want to give to a hea lthy 
individual." 
Ramer is co-d irector of the 
Washington University AIDS Clinica l 
Trials Unit, one of SO nationwide 
estab lished by the N IH to eva luate 
new AIDS therapies . He collected 
da ta from four AIDS patients who take 
part in the Multicenter AIDS Cohort 
Study in Baltimore, a group of homo­
sex ual men that prov ides a natu ral 
hi sto ry study of the di sease. In previous 
work, he stud ied the molecular 
composition of a key protein , the 
envelope prote in, in the same four 
patients. That work led to his conclu­
sion that the envelope protein changes 
ove r time, and that the sequence early 
in infec tion is linked to infection of 
macrophages, which are the maj or cel l 
infected in the brain and spinal cord. 
Infection of the macrophages is 
tho ught to be a key component in 
deve lopment of neurolog ical problems 
in AIDS patients. 
A Persistent Gene 
In the NEF study, Ratner rracked the 
NEF gene ove r five years and looked a t 
the mo lecular sequences of NEF during 
three po ints he labeled A, Band C. In 
all AIDS patients, the NEF gene is 
found intac t during the early stages of 
the infection . But it is not a lways 
intact at later stages. One th ing Ratner 
and T empleton wanted to de termine 
was the importance of NEF during 
various stages of infection. They found 
that the re were clones tha t develop 
deletions in the NEF gene over time , 
but there are a lso clones that do not 
have deletions over time. 
"We see almost a ll of the deletions 
occur late in the disease stage," Ratner 
notes. "I think the fact that we see 
NEF in tact early in disease provides 
addit ional proof that NEF probab ly is 
very important ea rly in infec tion and 
that later the virus will dispense with 
pa rts of the NEF ge ne li ke unneeded 
baggage. One of the key things Alan 
showed was that c lones with deleted 
NEF genes are not dead viruses , but 
are instead con tinuing to grow and 
rep licate within people." 
With the use of a sophisticated 
computer program that Templeton 
wrote and o ther a lgorithms, the 
populat ion biologis t created genetic 
trees to track the course of evo lution 
in the four patients. What he found in 
a ll patien ts was a random dis tribution 
of potent ially disruptive mutations of 
NEF gene func tion throughout the 
gene tree. 
"Ideally, what we hoped to see was 
that every time the NEF gene go t 
deleted , that would be the end of that 
lineage," Templeton explains. "When 
an important mutation occurs that 
disrupts gene func tion it means that 
lineage shou ld rapidly go ex tinct. But 
what we saw is that in some cases the 
lineages don't go ex tinct . The viruses 
keep pe rsisting and evo lving, meaning 
they're replicat ing." 
Ratner and Templeton specula te 
that deleted NEF genes may be ab le to 
persist by borrowing genetic material 
from other viruses and using that to 
replicate. The gene is loca ted next to 
anothe r importan t HI V gene, the LTR 
(long-terminal­
repeat); together the 
genes are major facto rs 
in letting HIV ente r 
human ce lls. 
HI V-1 Genome 

"One possibili ty is 
U3 RU5 vi f vpu tha t the NEF-deleted 
viruses are coex istingD I I . with viruses that have 
intact NEF genes andIT] DD- t a t -0 are using these as 
helper viruses for theirvpr 0- rev 
-D own rep lication, " 
T empleton says. 
"We've never fo und a 
The HIV genome is composed of fewer than a dozen genes of different sizes, represented in this patient where all the 
diagram by boxes and labeled with their abbreviated names, such as env., pol. and gag. Laid out NEF genes are lost in a 
here like cards on a table, they include the NEF gene (upper right), which is critical in the functiona l sense. 
invasion of HIV into human cells and is the focus of a study by Lee Ratner, M.D., Ph.D., and That 's why this helper 
Alan Templeton, Ph.D., who tracked its evolution in four patients. 










virus scheme is still quite feasible." 
Templeton says the NEF-deleted 
viruses may exist in an almost parasitic 
way with the other ones that have the 
NEF gene. This makes him all the 
more uncertain about a live vaccine 
because there is proof that the NEF­
deleted viruses can persist over time 
and evolve. 
Ratner and Templeton will 
collaborate on another HIV evolution­
ary study of 10 patien ts from the 
Washington University AIDS Clinical 
Trials Unit. Ratner has gathered data 
on the patients to determine if there 
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are certain HIV genes expressed only 
at certain times in the disease. 
Templeton again will provide his 
genetic analysis. 
"I think by understanding some of 
the aspects of how the virus operates, 
we'll eventually be able to develop 
better therapies and prevent some of 
the unfortunate complications of the 
disease," Ratner says. "One tremen­
dous tool we have now is knowledge of 
the sequences of hundreds of HIV 
isolates. We can make any kind of 
sequence change to these isolates and 
make a virus out of it and then see 
how that one change can alter the 
Lee Ratner, M.D., Ph.D., professor 
of medicine and of molecular microbI­
ology, says a vaccine based on a 
deleted NEF gene would be unreliable 
because HIV can thrive with or 
without the gene. 
biologica l behavior in culture. A live 
attenuated vaccine for animal models 
still is a useful research tool because it 
might tell us something about what's 
important for protecting against 
infection. The current research might 
yield some clues about how to design a 
dead vaccine, for instance." 
"I think the current study shows 
that by coupling the evolutionary 
analysis with the molecular genetic 
data, you get a really powerful infer­
ence that you couldn't get from one 
type of analysis alone," says 
Templeton.• 
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Match Day 1995 
THE annual Match Day took place on March 15 with 111 of tne 129 graduating medical 
students participating in tne na­
tional residency matcning program. 
Of tne participants, 64 percent 
received residency positions at tneir 
first choice of institution and 80 
percent matched one of their top 
tnree cnoices. The otner 18 students 
wno did not take part found posi­
tions independent of the matcning 
program or chose not to take 
residencies immediately. 
Primary care specialties of 
internal medicine, pediatrics and 
family practice captured tne interest 
of 61 students. Family practice 
attracted 10 students tnis year, up 
from three last year. Otolaryngology, 
diagnostic radiology and opnthal­
mology were fourth in popularity, 
witn each attracting seven students. 
Forty-two of the new physicians 
will remain in St. Louis, with 41 at 
Wasnington University Medical 
Center institutions. Otner popular 
destinations were California (12), 
Illinois (9), and Massacnusetts and 
Texas (each witn 8). 
Arizona 
Tucson 
University of Arizona Affil. Hosp. 
Pediatrics 
Jeffrey M. Couchman 
California 
Irvine 
University of California-Irvine 
Internal Medicine 




Kaiser Perm Med.-LA 
Pediatrics 

Dina K. Faulkner 

Merced 
Merced Community Med. 
Family Practice 
Patrick H. Zimmerman 
Fourth-year students Gregory Bauer, Ann Starr and Carl Kraus (L to R) celebrate 
at Match Day after learning where their medical training will continue. 
San Francisco 
California Pacific Med. Ctr. 
Internal Medicine 
Robert Striker 
University of California-SF 
Internal Med. 
Kenneth R. Hirsch 




Lance E. Jackson 
Ophthalmology 
Timothy J. McCulley 
Psychiatry 
Po Wei Wang 
Torrance 
Harbor-UCLA Med. Ctr. 
General Surgery 
David A. Oliak 
Ventura 
Ventura County Med. Ctr. 
Family Practice 





Jocelyn F. Bautista 













Floyd Med. Ctr. 
Family Practice 
Andrew A. Smith 






University of Iowa Hospital 
Internal Medicine 
Mark M. Belz 
Radiology 
S. Leon Burrows 
Illinois 
Ch.icago 
Children's Memorial Hospital 
Pediatrics 
Ajay Ahuja 
University of Chicago 
Ob-Gyn 
Carol F. Ellman 
Internal Medicine 

Brian K. Gehlbach 

Krista M. Johnson 

Carl N. Kraus 

Radiology 
Gregory S. Stacy 
McGaw Med. Ctr.-NW Univ. 
Internal Medicine 
Matthew D. Sirinek 
Ob-Gyn 
Ann Elizabeth Starr 
Urbana 
University of Illinois 
Family Practice 
James Hampton, Jr. 
Kansas 
Kansas City 
University of Kansas Sch. of Med. 
General Surgery 
Matthew T. Janzow 
Kentucky 
Lexington 
Univ. of Kentucky Med. Ctr. 
Pathology 
Nancy C. Muller 
Louisiana 
New Orleans 
Alton Oschner Fdn. 
Orthopaedic Surgery 
John M. Reynolds 
Maryland 
Baltimore 
University of Maryland 
Pediatrics 
Alice J. Ho 
Internal Medicine 
Douglas H. Pogue 
Johns Hopkins 
Pathology 




Bethesda Naval Hospital 
Pediatrics 





Christopher M. Palmer 
Boston 
Boston Univ. Med. Crr. 
Ophthalmology 
Vahid Feiz 
Brigham & Women's 
Pathology 
Jonathan Glickman 
Massachusetts Gen. Hospital 
Anesthesiology 
Francisco Delacruz-Newlan 












Blodgett Mem. Med. Ctr. 
Orthopaedic Surgery 
David M. Huebner 
Ann Arbor 
University of Michigan 
Neurology 





Thomas C. Robey 

Detroit 




Suzanne E. Rastorfer 
Minnesota 
Minneapolis 
Univ. of Minn. Hosp. & Clin. 
Radiology 
Joel C. Schein 










David J. Caccamo 
Missouri 
Columbia 
University Hosp. & Clinic 
Family Practice 










David J. Brown 









John J. Lehman 

Internal Medicine-Prelim. 









Gregory S. Bauer 

Ob-Gyn 
Mary Ruth Board 









John D. Rogakos 

Radiology 
Lawrence S. Kaskowitz 
Kraig R. Kirkpatrick 
Michael J. Naylor 
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Jewish Hosp ita l North Carolina Texas 
Interna l Medicine 
Durham DallasScott Wasserstrom 
Duke University Univ. of T exas SW Med. Ctr.Internal Medicine-Prelim. 
Neurosurgery Interna l MedicineBenjamin Hsu 
Amy B. Heimberger Todd K. HoriuchiSt. Johns Mercy 
Duke University Med. Ctr. Orthopaedic Surge ry Family Prac tice 
Psychiatry James C. Walter IICaroline Rudnick 
Eric L. Kirchmann HoustonSt. Louis Children's 
Baylor College ofMed.Pediatrics Ohio Plastic Surgery David A. Hunstad 
Douglas]. BallLori Kutka Columbus 
Internal MedicineKenneth An-Kai Liu Ohio State University 
Wai Leong Lee Nancy E. MacDonald Orthopaedic Surgery 
Cali C. Matheny Abdolreza Raissi San Antonio 
John Zempel Brooke Army Med . Ctr.DaytonJanet Kao PediatricsWright Patterson AFBKim Aiken Joel Ruff PediatricsHoward Goodkin Wilford HallDavid P. MillerBrenda Porter Bobbi Joy Chambers-Hawk 
St. Louis University General SurgeryPennsylvaniaOb-Gyn Mark A. Koler 
Kari A. Schmidt Oliver Philadelphia Internal Medicine 
Washington UniverSity Hahnemann Univ. Hospitals Brent A. Porter 
Oph tha lmology Orthopaedic Surgery 
Jonathan S ilbert Timothy E. Schende l UtahIvan Tarle Hosp. of University of Pennsylvania 
Salt Lake CityOtolaryngology Psychiatry 
University of Utah Affil. Hosp. Brian Lawner Ian C. Parker 
PediatricsJohn Park Sheryl Salaris 
Justin C. AlveyJohn C. Sun Internal Medicine 
Research Steven L. St. Peter 
Avinash Amin University of Pennsylvania Washington
Urology Internal Medicine Seattle
Howard E. Jarvis Phil Horwitz Providence Family Med. 
Jason Krumholtz Family PracticeRhode Island Lisa ErlangerNew York University of WashingtonProvidence 
NeurosurgeryNew York Rhode Island Hosp. 
Gregory D. Foltz Mt. Sinai Hospital Internal Medicine-Prelim. 
Univ. of Washington Affil.Internal Medicine Michael Kolodney 
Internal Medicine-PrimaryMichael E. Blam Emergency Medicine 
John D. ThorntonMt. Sinai School of Medicine Nona M. Perez 
Interna l MedicineOph tha lmology 
Robert YoungJonathan D. Primack Tennessee
North Shore Univ. Hosp. 
MemphisRadiology Wisconsin 
Univ. of TN College of MedicineDavid H. Miller MadisonPediatrics
Rochester Univ. of Wisconsin-St. MarysKristin D. Strawhecker 
Univ. Rochester/Strong Mem. Family Practice 
Internal Medicine Caroline E. Day 
Debbie C. Wu 
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The 1995 Reunion Award recipients (front, L to R): Llewellyn Sale, Jr., M.D. 
'40; Margaret C. Telfer, M.D. '65; Dennis P. Cantwell, M.D. '65; (back, L to R) 
Phillip E. Korenblat, M.D.; Philip O. Alderson, M.D. '70; Arnold Strauss, M.D. 
'70; and Gustav Schonfeld, M.D. '60. 
R E UN ION 1995 
Seven Honored With Awards 
for whom his profession and his 
pa tients are paramount." 
Gustav Schonfeld, M.D. '60 , is 
William B. Kountz Professor of 
Med icine and director of the 
atheroscle rosis, nutrition and lipid 
research div ision. He has been 
conducting li pid resea rch for more 
than 23 years . His expertise in the 
areas of lipoproteins and atheroscle­
rosis has made him sought after as a 
speaker and consultant around the 
world . The National Heart, Lung, 
and Blood Institute recently honored 
him with MERIT stat us, given only 
to investigators whose work is 
consistently outstanding. 
Arnold Strauss, M.D. '70, is 
directo r of the David Goldring 
Division of Ped iatric Cardio logy at 
S t. Louis Children's Hospital and 
professor of pediatrics and of 
molecular biology and pharmacol­Margaret C. Telfer, M.D. '65 ,Alumni Achievement 
ogy. He is internationa ll y known foris director of the Hemophilia CenterAwards investiga tion into the eva luation at Michael Reese Hospi tal in 
and treatment of heart disease in Chicago, Illinois, where she is alsoPhilip O. Alderson, M.D. '70, is 
children. Mos t recently, he has inter im director of the division ofJames Picker Professor of Radiology directed a study that identified a hemato logy/onco logy. She dedicates and chairman of the Department of gene tic defect which causes Suddenher career to the ca re and treatmentRadiology at Columbia-Presbyterian Infant Death Syndrome in some of hemophiliac patients and hasMedica l Center in New York City. infants.pioneered home infusion as a He has made major contributions in 
treatment alternat ive. As co-directorpulmonary and cardiovascular 
of the Michael Reese HIV Clinic,nuclear medicine and is acknowl­ Distinguished
she has ass isted patients th rough edged as a superb teacher and 
hemorrhag iC crises and the problems Service Awardclinical nuclear rad io logist. He has 
of AIDS.made more than 200 presentations at Phillip E. Korenblat, M.D. , is 
meetings and is a prolific author. 
medica l director of The Asthma 
Dennis P. Cantwell, M.D. '65, Center and the Clinical ResearchAlumni/Facultyis Joseph Campbell Professor of Center at Barnes \Vest County
Child Psychiatry at the University of Awards Hospital and professor of clinica l 
California at Los Ange les School of 
medicine. He is the force behind theLlewellyn Sale, Jr., M.D. '40, is Medicine. 
success of an approach that empow­professor of clinical medicine andHis work in child psychiatry sets 
ers patients and their families in thepresident of Central Medical Group,the pace for much of the research in treatment of as thma . His research Inc. For 20 years he was associate the field. He led the way in estab­ focuses on medications for as thmadirector of the Department oflishing a clinical depression diagno­
and allergies. He is listed in The BestInternal Medic ine at Jewish Hospi­sis in children and is an expert on Doctors in America, 1994-95 , and thetal, and he directed the S tudentattent ion deficit hyperactivity Department of Medicine a t Jewish Health Service on the Hilltopdisorder. Highly respected as a Hospital named him T eacher of theCampus for 18 years . He is described clinician and teacher, he is fre­ Year in 1986 .•as a "fine teacher and role model," quentl y sought for consu ltation on 
and "a forthright and honest persondifficult cases. 
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The Class of 1935 shares memories during the Friday night dinner. 
From left: reunion social chair Dr. Richard A. Sutter, Jarry Maughs, 
Dr. Sydney Maughs, Dr. Richard Mcilroy, Mercy Mcilroy, Dr. Mark 
Gregory and (across the table) Dr. Patricia Gregory (director of 
corporate and foundation relations In the medical alumni office), 
Dr. C. Rush McAdam, reunion gift chair Dr. Jerry Fiance, Rosemary 
Fiance and Betty Henby Sutter.11 
) J 
Alumni listen to a presentation during a tour of 
the new Mallinckrodt Institute of Radiology 
Imaging Center. 
Drs. Helmuth "Hap" Hoff, Jay Gibson, and reunion 
gift co-chair Sam Guze at the 50th reunion of the 
Class of 1945. 
Reunion social chair Dr. Llewellyn Sale (arms crossed) enjoys a 
light moment with his Class of 1940 classmates: Drs. Bill 
Curtis, reunion gift chair Robert Anschuetz and John Skinner, 
and spouses Frances Curtis, Ella Anschuetz, Betty Skinner and 
Kathleen Sale. 
Paula Clayton, M.D. '60, brings her classmates up to 
date on her activities, while Boyd Terry, M.D. '60, 
and Carolyn Terry, M.D. '60, listen. 
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James Davis, M.D. '45, and Florri"a Davis sample 
the fare at the welcoming party. 
Miles Whitener, M.D. '55 and social chair for his class, 
reads letters from classmates unable to attend the 
reunion. Around the table from left: reunion gift co-chair 
Robert C. Drews, M.D. '55, Lorene Drews, William Paris, 
M.D. '55, Ann Paris, Glen King, M.D. '55, and Scotty King. 
Reunion gift committee member Joann Data, M.D. '70, WUMCAA 
president and class gift chair David Ortbals, M.D. '70, Jane Brassel, 
Doris Miller, Alec Mi"er, M.D. '70, and Marilyn Escobedo, M.D. '70. 
Reunion social chair Meredith Payne, M.D. '50, 
emcees the class dinner. 
Winston Tustison, M.D. '60 and a 
certified financial planner, advises 
fellow alumni about retirement 
strategies during the Saturday 
luncheon. 
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Members of the Class of 1970 at the Dean's Lunch in Olin 
Residence Hall. From left: reunion gift committee member 
Ronald Gaskin, Tom McMahan, Lyle Pahnke, David Ortbals, 
Donald Anderson, Gene Crews, Marilyn Escobedo, reunion 
social chair Francisco "Paco" Garriga, Ron Marshall, Eric 
Zurbrugg and Jo Beamer Zurbrugg. 





social chair Dr. 
David Clifford 
arrive at the Ritz­
Carlton for the 
Class of '75 
dinner. 
Devoree Clifton-Crist, M.D. '80, and Michele 
Bloch, M.D. '80, reminisce. 
Gustav Schonfeld, M.D. '60 and reunion 
social chair, is surrounded by family 
members who admire his Alumni/Faculty 
Award. 
Class of 1975 members, from left: Drs. Doug Mayers, Jo-Ellyn 
Ryall, Bruce Schainker, Ed Hume and his spouse, Susan Ferrara, 
at the cocktail party. 
Bradley A. Evanoff, 
M.D., M.P.H, the 
Richard A. and 
Elizabeth Henby 




Medicine, makes a 
presentation at the 
reunion scientific 
program. 
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,­
1985 classmates Howard Yerman, Vera Bennett 
and Karen Mathews. 
Reunion class social 
chair lVIarshall 
Conrad, M.D. '45, 
responds to a tribute 
to the 50th reunion 
celebrants and 
welcomes the Class 
of 1995 into 
WUMCAA. 
AI Baudendistel, M.D. '85, Peter Weiss, M.D. '85, Sharon Weiss and Kathy Pohl and Tim Frost, M.D. '85, enjoy 
reunion class social chair Herluf Lund, M.D. '85. the class photo display. 
Retiring Chancel· 
lor William H. 
Danforth, M.D., 
welcomes alumni 
and friends to the 
reunion banquet. 
The guests 




his 24 years as 
chancellor. 
1. 
William A. Peck, M.D. , executive vice chancellor for 
medical affairs and dean of the School of Medicine, 
and David Ortbals, M.D. '70 and 1994-95 president of 
WUMCAA, share a light moment. 
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Reunion social chair Tom Ott, M.D. '65, and Mary 
Ott enjoy the class dinner. 
William A. Peck, M.D., executive vice chancel­
lor and dean, presents the 1995 Distinguished 
Service Award to Phillip E. Korenblat, M.D. 
Abdolreza Raissi, 
president of 
the Class of 
1995, responds 
to Dr. Marshall 
Conrad's remarks. 
Members of the Class of 1995 pose with Dean Peck after 
the banquet. 
Bill Tisdale, M.D. '55, and his wife, Pat, 
dance to the music of the Hot Docs. 
WUMCAA president-elect, Richard A. Blath, M.D. '71, and 
1994-'95 WUMCAA President, David Ortbals, M.D. '70. 
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Colorful Hawaiian leis complemented Todd Horiuchi's mortarboard at 
commencement exercises held on the Hilltop Campus on May 19. The 
School of Medicine conferred 97 M.D. degrees, 19 M.O,fPh.O. degrees 
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At a reception following the dedication of the Bernard Becker Medical Library, Bernard 
Becker, M.D. , professor and emeritus head of the Department of Ophthalmology and Visual 
Sciences, shows a keepsake program to his granddaughter, Amariah Becker, and his son, 
Robert Becker. Dr. Becker chaired the committee that oversaw design and construction of 
the eight-level , 113,OOO-square-foot library, which was completed in 1989. The Becker 
Collection of rare books on ophthalmology and the visual sciences is a major component of 
the library 's internationally recognized rare book collection. Becker served as head of 
ophthalmology from 1953 through 1988. 
